<DOC>
	<DOCNO>NCT01078038</DOCNO>
	<brief_summary>This randomize study multi-center , randomize , study compare efficacy sirolimus versus everolimus-eluting stent implantation long coronary lesion .</brief_summary>
	<brief_title>Percutaneous Treatment LONG Native Coronary Lesions With Drug-Eluting Stent-III ( LONG-DES-III )</brief_title>
	<detailed_description>Following angiography , patient significant diameter stenosis &gt; 50 % lesion length ( &gt; 25mm ) require single multiple long-stent placement ( total stent length &gt; 28mm ) visual estimation eligible LONG-DES III trial inclusion exclusion criterion randomize 1:1 ) sirolimus-eluting b ) everolimus-eluting stent stratify randomization method .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>The patient must least 18 year age . Significant native coronary artery stenosis ( &gt; 50 % visual estimate ) lesion length 25mm , require single multiple long stent placement ( &gt; =28mm ) Patients silent ischemia , stable unstable angina pectoris , ad NonSTelevation myocardial infarction The patient guardian agree study protocol schedule clinical angiographic followup , provide informed , write consent , approve appropriate Institutional Review Board/Ethical Committee respective clinical site . Any contraindication follow medication : aspirin , heparin , clopidogrel , stainless steel , contrast agent , sirolimus , everolimus . An elective surgical procedure plan would necessitate interruption antiplatelet drug first 6 month post enrollment . Acute STsegmentelevation MI cardiogenic shock Terminal illness life expectancy &lt; 1 year Patients actively participate another drug device investigational study , complete primary endpoint followup period . Instent restenosis target vessel ( either bare metal stent drugeluting stent segment , nontarget vessel ISR permit ) Patients EF &lt; 30 % . Serum creatinine level &gt; =3.0mg/dL dependence dialysis . Patients leave main stem stenosis ( &gt; 50 % visual estimate ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Coronary Artery Disease</keyword>
	<keyword>Stent</keyword>
</DOC>